Ten Seeger Weiss Attorneys Named to Lawdragon’s 2025 500 Leading Plaintiff Financial Lawyers List

We are proud to announce that ten Seeger Weiss attorneys have been selected to Lawdragon’s 2025 Leading Plaintiff Financial Lawyers guide list, which honors attorneys who represent plaintiffs in complex financial litigation.

June 10, 2025

Lawdragon 500 Leading Plaintiff Financial Lawyers

We are proud to announce that ten Seeger Weiss attorneys have been selected to Lawdragon’s 2025 Leading Plaintiff Financial Lawyers guide list, which honors attorneys who represent plaintiffs in complex financial litigation.

Congratulations to Parvin Aminolroaya, Christopher Ayers, Ben Barnett, David R. Buchanan, Steven Daroci, Shauna Itri, Jeremy Kasha, Jennifer Scullion, Christopher Seeger, and Stephen Weiss on this well-earned recognition.

This award highlights lawyers who represent plaintiffs in securities, antitrust, consumer protection, data privacy, whistleblower, and class action matters involving significant financial harm.

Lawdragon’s selection methodology is rooted in over 30 years of legal journalism and industry insight. Their editorial team evaluates thousands of candidates across the country, focusing on those who demonstrate not only legal excellence but also leadership, integrity, and a consistent track record of success.

The recognized attorneys have led litigation against large corporations and financial institutions, often taking on roles as court-appointed lead counsel in cases of national importance.

No aspect of this advertisement has been approved by the Supreme Court of New Jersey. The selection methodology can be found here.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More